| Published: May 2017 | Report Code: LS10993 | Available Format: | Pages: 151 |
Note: This report can also be updated as of date and delivered within 1-2 workings days of purchase confirmation
This report includes the chronic obstructive pulmonary disease therapeutics pipeline analysis as of May 2017, to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, combination therapies, targets and mechanism of action, and drug origin with relevance to chronic obstructive pulmonary disease.
Chronic Obstructive Pulmonary Disease Therapeutics Pipeline Analysis
Prescient & Strategic (P&S) Intelligence, a brand of P&S Market Research Private Limited, was born out of the idea of helping businesses achieve breakthroughs through intelligent decision making, underpinned by a thorough understanding of industry dynamics
Enquire Before Purchase